Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1390777 NEW YORK, NY
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$346,654
+$63,785 QoQ
Shares Held
24,673
-6.1% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 87 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. LYEL ranks #268 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in LYEL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $346,654 24,673
2025-03-31 $282,869 525,782
2024-12-31 $336,499 525,782
2024-09-30 $725,577 525,782
2024-06-30 $974,350 671,966
2024-03-31 $1,412,657 633,479
2023-12-31 $1,282,372 661,017
2023-09-30 $972,493 661,561
2023-06-30 $2,096,232 659,193
2023-03-31 $1,543,298 653,940
2022-12-31 $2,277,048 656,210
2022-09-30 $4,828,680 658,756
2022-06-30 $3,581,181 549,261
2022-03-31 $1,970,337 390,166
2021-12-31 $551,675 71,276
2021-09-30 $867,546 58,618